Elevated plasma TGs are a marker of insulin resistance and the metabolic syndrome, resulting partly from the suppression of LPL expression in adipose tissue by inflammatory cytokines such as TNF-α (18–20). This evidence concerns the gene LPL and Insulin resistance.